Pediatric Patients
Showing all 4 results
-
Atopic Dermatitis Study
This clinical trial is being conducted to evaluate biomarkers of Atopic Dermatitis in pediatric patients whose disease is not adequately controlled with topical prescription therapies or when those therapies are not medically advisable.
Read more
Criteria & Qualifications: • Males and Females in good general health
• Patients with moderate to severe AD whose disease is not adequately controlled with topical therapies
• Must be 0 years to 11 years old
Compensation: Contact us for more information -
Crohn’s Disease Study
Crohn’s disease is a chronic inflammatory condition that affects the digestive tract. This clinical trial is being conducted to evaluate the efficacy and safety of guselkumab & golimumab in participants with Crohn’s disease. Criteria & Qualifications: • Is at least 18 years of age or older. • Diagnosis of Crohn's disease (CD) for at least 3 months. • Is willing to provide medical records. Compensation: Contact us for more information
Read more -
Meningitis Study
This clinical trial is being conducted to evaluate the safety and immunogenicity of a Meningococcal vaccine in infants 6 weeks through 12 weeks of age, when administered concomitantly with Pneumococcal conjugate vaccine and other recommended routine infant vaccines (RIV).
Read more
Criteria & Qualifications:
• Males and Females in good general health.
• Must be 6 weeks to 12 weeks old.
Compensation: Contact us for more information -
Pediatric COVID-19 Study
This clinical trial is being conducted to evaluate the Safety, Tolerability, Reactogenicity, and Effectiveness of the SARS-CoV-2 Vaccine in Healthy Children 6 Months to Less Than 12 Years of Age.
Read more
Criteria & Qualifications: • Males and Females in good general health.
• Must be between the age of 6 months and 12 years.
Compensation: Contact us for more information
